docetaxel (T)

DRUG2 trials

Sponsors

Fudan University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

Breast Cancer

Phase 2

Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer

Fudan UniversityBreast Cancer

Start: 2011-12-31End: 2013-07-31Target: 60Updated: 2012-02-07

Phase 3

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

RecruitingNCT05159193

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityBreast Cancer

Start: 2021-12-20End: 2028-01-31Target: 372Updated: 2024-02-02

Related Papers

Randomized phase II trial comparing docetaxel with or without low-dose metronomic oral cyclophosphamide in first-line treatment of non-triple-negative advanced breast cancer.

Journal of Clinical Oncology2014-05-20